Zimmer Biomet Holdings Inc
$ 90.53
-0.26%
29 Dec - close price
- Market Cap 17,988,940,000 USD
- Current Price $ 90.53
- High / Low $ 91.42 / 90.14
- Stock P/E 22.52
- Book Value 64.36
- EPS 4.03
- Next Earning Report 2026-02-05
- Dividend Per Share $0.96
- Dividend Yield 1.06 %
- Next Dividend Date 2026-01-30
- ROA 0.04 %
- ROE 0.06 %
- 52 Week High 113.87
- 52 Week Low 85.33
About
Zimmer Biomet Holdings Inc. is a leading global medical device company based in Warsaw, Indiana, renowned for its focus on orthopedic reconstructive products and a broad spectrum of surgical and non-surgical solutions. With a robust innovation pipeline and strategic collaborations, Zimmer Biomet is committed to enhancing patient outcomes across orthopedic, surgical, and dental sectors. The company's emphasis on quality and innovation solidifies its position as a critical contributor to the evolving healthcare landscape, effectively addressing the diverse needs of healthcare professionals and patients around the world.
Analyst Target Price
$102.04
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-10-30 | 2025-08-07 | 2025-05-05 | 2025-02-06 | 2024-10-30 | 2024-08-07 | 2024-05-02 | 2024-02-08 | 2023-11-07 | 2023-08-01 | 2023-05-02 | 2023-02-03 |
| Reported EPS | 1.9 | 2.07 | 1.81 | 2.31 | 1.74 | 2.01 | 1.94 | 2.2 | 1.65 | 1.82 | 1.89 | 1.88 |
| Estimated EPS | 1.88 | 1.98 | 1.77 | 2.29 | 1.74 | 1.99 | 1.87 | 2.15 | 1.6 | 1.81 | 1.64 | 1.83 |
| Surprise | 0.02 | 0.09 | 0.04 | 0.02 | 0 | 0.02 | 0.07 | 0.05 | 0.05 | 0.01 | 0.25 | 0.05 |
| Surprise Percentage | 1.0638% | 4.5455% | 2.2599% | 0.8734% | 0% | 1.005% | 3.7433% | 2.3256% | 3.125% | 0.5525% | 15.2439% | 2.7322% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-05 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 2.38 |
| Currency | USD |
Previous Dividend Records
| Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-01-30 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 |
| Amount | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 |
Next Dividend Records
| Dividend per share (year): | $0.96 |
| Dividend Yield | 1.06% |
| Next Dividend Date | 2026-01-30 |
| Ex-Dividend Date | 2025-12-30 |
Recent News: ZBH
2025-12-30 04:11:13
Stryker (SYK) shares closed down 0.5% in cautious year-end trading, with investors focused on a December 31st dividend record date and a January 1st leadership change as Spencer Stiles becomes President and COO. The stock is holding near a $350 support level, and the company has declared a quarterly dividend of $0.88 per share. The broader market also saw a pullback in the final week of 2025.
2025-12-29 07:09:09
The Collagen Meniscus Implant Market is projected for strong growth from 2025 to 2032 due to rising demand, expanding applications, and technological advancements. A new report by Coherent Market Insights details market size, revenue trends, key growth factors, and competitive landscapes, offering actionable insights for data-driven decisions. Leading companies like Zimmer Biomet Holdings Inc. and RTI Surgical Holdings Inc. are highlighted in this comprehensive analysis.
2025-12-27 13:24:49
Kempner Capital Management Inc. has significantly reduced its stake in Zimmer Biomet Holdings, Inc., selling 27,095 shares, which accounts for 46.3% of its previous holding. Following this transaction, the firm now owns 31,401 shares of Zimmer Biomet, valued at approximately $3.09 million, making it the 15th largest position in its portfolio. The medical equipment provider recently reported earnings that slightly beat EPS expectations but missed revenue forecasts, while analysts hold a "Hold" rating with an average target price of $107.50 for the stock.
2025-12-26 12:32:27
QSM Asset Management Ltd significantly increased its holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) during the third quarter, making it their largest position. The medical equipment provider also reported strong third-quarter earnings, beating analyst EPS estimates and showing a 9.6% year-over-year revenue increase with positive FY 2025 guidance. Institutional investors hold a substantial portion of the company's stock, and Zimmer Biomet recently declared a quarterly dividend.
2025-12-26 06:08:30
A new report by Coherent Market Insights projects robust growth for the Da Vinci Robotic Surgical System Market between 2025 and 2032. The report analyzes market trends, growth opportunities, and competition, highlighting key players like Intuitive Surgical, Medtronic, and Siemens Healthineers. It aims to provide critical insights for businesses, investors, and strategists in the healthcare technology sector.
2025-12-25 13:05:52
Voya Investment Management LLC reduced its stake in Zimmer Biomet Holdings, Inc. by 18.3% in Q3, now holding 54,362 shares valued at $5.36 million. Despite beating Q3 EPS estimates, the medical equipment provider slightly missed revenue expectations, though quarterly revenue rose 9.6% year-over-year. Analysts currently rate Zimmer Biomet as a "Hold" with an average price target of $107.50, and the company announced a quarterly dividend of $0.24 per share.
